Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 948264, 13 pages
http://dx.doi.org/10.1155/2014/948264
Research Article

Beta-Catenin and Epithelial Tumors: A Study Based on 374 Oropharyngeal Cancers

1Department of Laboratory Medicine, Institute of Pathological Anatomy, Foundation for Research and Therapy “Giovanni Paolo II”, UCSC, 86100 Campobasso, Italy
2Department of Clinical and Experimental Medicine, Section of Pathological Anatomy, University of Foggia, 71121 Foggia, Italy
3Department of Otolaryngology, Head and Neck Surgery and Oncology, Medical School, University of Michigan, Ann Arbor, MI 48109, USA
4Department of Pathology, Medical School, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
5Department of Economic Sciences, Mathematics and Statistics, University of Foggia, 71122 Foggia, Italy
6Laboratory of Preclinical and Translational Research, IRCCS-CROB, Oncological Reference Centre of Basilicata, 85028 Rionero in Vulture, Italy
7Institute of Biochemistry, SUN, 80100 Napoli, Italy
8Section of Pathological Anatomy, Polytechnic University of Marche, 60100 Ancona, Italy
9Section of Pathological Anatomy, Department of Advanced Biomedical Sciences, University of Napoli “Federico II”, 80100 Napoli, Italy
10Section of Pathological Anatomy, National Cancer Institute “G. Pascale Foundation”, 80100 Napoli, Italy
11Section of Anatomy and Histology, Department of Bio-Medical Sciences, University of Catania, 95100 Catania, Italy
12Section of Maxillo-Facial Surgery, Department of Experimental Science in Medicine and Dentistry, University of Messina, 98100 Messina, Italy
13IRCCS-CROB, Oncological Reference Centre of Basilicata, 85028 Rionero in Vulture, Italy
14Section of Oral Pathology, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy

Received 1 August 2013; Revised 26 October 2013; Accepted 17 November 2013; Published 8 January 2014

Academic Editor: Franco M. Buonaguro

Copyright © 2014 Angela Santoro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Wennerberg, “Predicting response to therapy of squamous cell carcinoma of the head and neck,” Anticancer Research, vol. 16, no. 4, pp. 2389–2396, 1996. View at Google Scholar · View at Scopus
  2. J. A. Woolgar, “Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma,” Oral Oncology, vol. 42, no. 3, pp. 229–239, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Bundgaard, S. M. Bentzen, J. Wildt, F. B. Sørensen, H. Søgaard, and J. E. Nielsen, “Histopathologic, stereologic, epidemiologic, and clinical parameters in the prognostic evaluation of squamous cell carcinoma of the oral cavity,” Head and Neck, vol. 18, no. 2, pp. 142–152, 1996. View at Google Scholar · View at Scopus
  4. P. Choi, C. D. Jordan, E. Mendez et al., “Examination of oral cancer biomarkers by tissue microarray analysis,” Archives of Otolaryngology—Head and Neck Surgery, vol. 134, no. 5, pp. 539–546, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Oh and L. Mao, “Biomarkers in head and neck carcinoma,” Current Opinion in Oncology, vol. 9, no. 3, pp. 247–256, 1997. View at Google Scholar · View at Scopus
  6. B. M. Gumbiner and P. D. McCrea, “Catenins as mediators of the cytoplasmic functions of cadherins,” Journal of Cell Science, vol. 106, no. 17, pp. 155–158, 1993. View at Google Scholar · View at Scopus
  7. T. Takayama, H. Shiozaki, S. Shibamoto et al., “β-catenin expression in human cancers,” American Journal of Pathology, vol. 148, no. 1, pp. 39–46, 1996. View at Google Scholar · View at Scopus
  8. C. Yost, M. Torres, J. R. Miller, E. Huang, D. Kimelman, and R. T. Moon, “The axis-inducing activity, stability, and subcellular distribution of β-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3,” Genes and Development, vol. 10, no. 12, pp. 1443–1454, 1996. View at Google Scholar · View at Scopus
  9. D. L. Rimm, J. H. Sinard, and J. S. Morrow, “Reduced α-catenin and E-cadherin expression in breast cancer,” Laboratory Investigation, vol. 72, no. 5, pp. 506–512, 1995. View at Google Scholar · View at Scopus
  10. A. Valizadeh, A. J. Karayiannakis, I. El-Hariry, W. Kmiot, and M. Pignatelli, “Expression of E-cadherin-associated molecules (α-, β-, and γ-catenins and p120) in colorectal polyps,” American Journal of Pathology, vol. 150, no. 6, pp. 1977–1984, 1997. View at Google Scholar · View at Scopus
  11. B. Romagnolo, D. Berrebi, S. Saadi-Keddoucci et al., “Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated β-catenin,” Cancer Research, vol. 59, no. 16, pp. 3875–3879, 1999. View at Google Scholar · View at Scopus
  12. X. Ji, A. S. Woodard, D. L. Rimm, and E. R. Fearon, “Transcriptional defects underlie loss of E-cadherin expression in breast cancer,” Cell Growth and Differentiation, vol. 8, no. 7, pp. 773–778, 1997. View at Google Scholar · View at Scopus
  13. O. Aguilera, A. Muñoz, M. Esteller, and M. F. Fraga, “Epigenetic alterations of the Wnt/β-catenin pathway in human disease,” Endocrine, Metabolic and Immune Disorders—Drug Targets, vol. 7, no. 1, pp. 13–21, 2007. View at Google Scholar · View at Scopus
  14. M. Lacroix-Triki, F. C. Geyer, M. B. Lambros et al., “β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast,” Modern Pathology, vol. 23, no. 11, pp. 1438–1448, 2010. View at Google Scholar
  15. M. Aoki, A. Hecht, U. Kruse, R. Kemler, and P. K. Vogt, “Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 1, pp. 139–144, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. O. Huber, R. Korn, J. McLaughlin, M. Ohsugi, B. G. Herrmann, and R. Kemler, “Nuclear localization of β-catenin by interaction with transcription factor LEF-1,” Mechanisms of Development, vol. 59, no. 1, pp. 3–10, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Bafico, A. Gazit, T. Pramila, P. W. Finch, A. Yaniv, and S. A. Aaronson, “Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling,” The Journal of Biological Chemistry, vol. 274, no. 23, pp. 16180–16187, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Mann, M. Gelos, A. Siedow et al., “Target genes of β-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 4, pp. 1603–1608, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. R. K. Yantiss, M. Goodarzi, X. K. Zhou et al., “Clinical, pathologic, and molecular features of early-onset colorectal carcinoma,” The American Journal of Surgical Pathology, vol. 33, no. 4, pp. 572–582, 2009. View at Google Scholar · View at Scopus
  20. P. J. Kim, J. Plescia, H. Clevers, E. R. Fearon, and D. C. Altieri, “Survivin and molecular pathogenesis of colorectal cancer,” The Lancet, vol. 362, no. 9379, pp. 205–209, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. F. H. Brembeck, M. Rosário, and W. Birchmeier, “Balancing cell adhesion and Wnt signaling, the key role of β-catenin,” Current Opinion in Genetics and Development, vol. 16, no. 1, pp. 51–59, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Katoh and M. Katoh, “Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA (review),” International Journal of Molecular Medicine, vol. 22, no. 3, pp. 271–275, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Iwai, W. Katagiri, C. Kong, S. Amekawa, M. Nakazawa, and Y. Yura, “Mutations of the APC, beta-catenin, and axin 1 genes and cytoplasmic accumulation of beta-catenin in oral squamous cell carcinoma,” Journal of Cancer Research and Clinical Oncology, vol. 131, no. 12, pp. 773–782, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. Z.-G. Cai, X.-J. Shi, Y. Gao, M.-J. Wei, C.-Y. Wang, and G.-Y. Yu, “β-catenin expression pattern in primary oral squamous cell carcinoma,” Chinese Medical Journal, vol. 121, no. 19, pp. 1866–1870, 2008. View at Google Scholar · View at Scopus
  25. A. Gasparoni, A. Chaves, L. Fonzi, G. K. Johnson, G. B. Schneider, and C. A. Squier, “Subcellular localization of beta-catenin in malignant cell lines and squamous cell carcinomas of the oral cavity,” Journal of Oral Pathology and Medicine, vol. 31, no. 7, pp. 385–394, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Barnes, J. W. Eveson, P. Reichart, and D. Sidranski, Pathology and Genetics of Head and Neck Tumours, World Health Classification of Tumours, IARC, Lyon, France, 2005.
  27. G. Pannone, P. Bufo, A. Santoro et al., “WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors,” Oncology Reports, vol. 24, no. 4, pp. 1035–1041, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Franco, F. Boscia, V. Gigantino et al., “GPR30 is overexpressed in post-puberal testicular germ cell tumors,” Cancer Biology and Therapy, vol. 11, no. 6, pp. 609–613, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Fedele, R. Franco, G. Salvatore et al., “PATZI gene has a critical role in the spermatogenesis and testicular tumours,” Journal of Pathology, vol. 215, no. 1, pp. 39–47, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Papagerakis, G. Pannone, A. H. Shabana et al., “Aberrant beta-catenin and LEF1 expression may predict the clinical outcome for patients with oropharyngeal cancer,” International Journal of Immunopathology and Pharmacology, vol. 25, no. 1, pp. 135–146, 2012. View at Google Scholar
  31. P. Duesberg, R. Stindl, and R. Hehlmann, “Origin of multidrug resistance in cells with and without multidrug resistance genes: chromosome reassortments catalyzed by aneuploidy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 20, pp. 11283–11288, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. P. McCullagh, “Regression models for ordinal data,” Journal of the Royal Statistical Society B, vol. 42, no. 2, pp. 109–142, 1980. View at Google Scholar
  33. D. M. Parkin, S. L. Whelan, J. Ferlay, L. Raymond, and J. Young, Eds., Cancer Incidence in Five Continents, vol. 7 of IARC Scientific Publication no. 143, International Agency for Research on Cancer, Lyon, France, 1997.
  34. S. Choi and J. N. Myers, “Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy,” Journal of Dental Research, vol. 87, no. 1, pp. 14–32, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. O. Aguilera, A. Muñoz, M. Esteller, and M. F. Fraga, “Epigenetic alterations of the Wnt/β-catenin pathway in human disease,” Endocrine, Metabolic and Immune Disorders—Drug Targets, vol. 7, no. 1, pp. 13–21, 2007. View at Google Scholar · View at Scopus
  36. H. Yamamoto, “Regulation of Wnt signaling pathway and its relationship with tumorigenesis,” Seikagaku, vol. 80, no. 12, pp. 1079–1093, 2008. View at Google Scholar · View at Scopus
  37. P. Bovolenta, P. Esteve, J. M. Ruiz, E. Cisneros, and J. Lopez-Rios, “Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease,” Journal of Cell Science, vol. 121, no. 6, pp. 737–746, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Baretton, X. Li, C. Stoll, E. Fischer-Brandies, M. Schmidt, and U. Löhrs, “Prognostic significance of DNA ploidy in oral squamous cell carcinomas. A retrospective flow and image cytometric study with comparison of DNA ploidy in excisional biopsy specimens and resection specimens, primary tumors, and lymph node metastases,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and, vol. 79, no. 1, pp. 68–76, 1995. View at Google Scholar · View at Scopus
  39. A. Donadini, M. Maffei, A. Cavallero et al., “Oral cancer genesis and progression: DNA near-diploid aneuploidization and endoreduplication by high resolution flow cytometry,” Cellular Oncology, vol. 32, no. 5-6, pp. 373–383, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Duesberg, A. Fabarius, and R. Hehlmann, “Aneuploidy, the primary cause of the multilateral genomic instability of neoplastic and preneoplastic cells,” IUBMB Life, vol. 56, no. 2, pp. 65–81, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. S. B. Baylin and J. E. Ohm, “Epigenetic gene silencing in cancer—a mechanism for early oncogenic pathway addiction?” Nature Reviews Cancer, vol. 6, no. 2, pp. 107–116, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. K.-T. Yeh, J.-G. Chang, T.-H. Lin et al., “Correlation between protein expression and epigenetic and mutation changes of Wnt pathway-related genes in oral cancer,” International Journal of Oncology, vol. 23, no. 4, pp. 1001–1007, 2003. View at Google Scholar · View at Scopus
  43. P. Polakis, “The many ways of Wnt in cancer,” Current Opinion in Genetics and Development, vol. 17, no. 1, pp. 45–51, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Wilding, K. H. Vousden, W. P. Soutter, P. D. McCrea, R. Del Buono, and M. Pignatelli, “E-cadherin transfection down-regulates the epidermal growth factor receptor and reverses the invasive phenotype of human papilloma virus- transfected keratinocytes,” Cancer Research, vol. 56, no. 22, pp. 5285–5292, 1996. View at Google Scholar · View at Scopus
  45. Y. Sogabe, H. Suzuki, M. Toyota et al., “Epigenetic inactivation of SFRP genes in oral squamous cell carcinoma,” International Journal of Oncology, vol. 32, no. 6, pp. 1253–1261, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. G. D'Souza, A. R. Kreimer, R. Viscidi et al., “Case-control study of human papillomavirus and oropharyngeal cancer,” The New England Journal of Medicine, vol. 356, no. 19, pp. 1944–1956, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. M. L. Gillison, W. M. Koch, R. B. Capone et al., “Evidence for a causal association between human papillomavirus and a subset of head and neck cancers,” Journal of the National Cancer Institute, vol. 92, no. 9, pp. 709–720, 2000. View at Google Scholar · View at Scopus
  48. P. M. Weinberger, Z. Yu, B. G. Haffty et al., “Molecular classification identifies a subset of human papillomavirus- associated oropharyngeal cancers with favorable prognosis,” Journal of Clinical Oncology, vol. 24, no. 5, pp. 736–747, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. S. D. Hayward, J. Liu, and M. Fujimuro, “Notch and Wnt signaling: mimicry and manipulation by gamma herpesviruses,” Science's STKE, vol. 2006, no. 335, p. re4, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Fujimuro and S. D. Hayward, “Manipulation of glycogen-synthase kinase-3 activity in KSHV-associated cancers,” Journal of Molecular Medicine, vol. 82, no. 4, pp. 223–231, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. J. A. Morrison, A. J. Klingelhutz, and N. Raab-Traub, “Epstein-Barr virus latent membrane protein 2A activates β-catenin signaling in epithelial cells,” Journal of Virology, vol. 77, no. 22, pp. 12276–12284, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Rampias, E. Boutati, E. Pectasides et al., “Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells,” Molecular Cancer Research, vol. 8, no. 3, pp. 433–443, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. G. Pannone, A. Santoro, F. Carinci et al., “Double demonstration of oncogenic high risk human papilloma virus DNA and HPV-E7 protein in oral cancers,” International Journal of Immunopathology and Pharmacology, vol. 24, no. 2, supplement, pp. 95–101, 2011. View at Google Scholar
  54. G. Pannone, V. Rodolico, A. Santoro et al., “Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: P16 Immunohistochemistry, consensus PCR HPV-DNA, and in situ hybridization,” Infectious Agents and Cancer, vol. 7, article 4, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. G. Aquino, G. Pannone, A. Santoro et al., “pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma: a tissue-microarray study with clinic-pathological correlations,” Cancer Biology & Therapy, vol. 13, no. 11, pp. 1–11, 2012. View at Google Scholar
  56. G. Pannone, A. Santoro, A. Feola et al., “The role of E-cadherin down-regulation in oral cancer: Cdh1 gene expression and epigenetic blockage,” Current Cancer Drug Targets, vol. 14, no. 2, 2014. View at Google Scholar
  57. M. di Domenico, G. M. Pierantoni, A. Feola et al., “Prognostic significance of N-cadherin expression in oral squamous cell carcinoma,” Anticancer Research, vol. 31, no. 12, pp. 4211–4218, 2011. View at Google Scholar · View at Scopus
  58. R. Fodde and T. Brabletz, “Wnt/β-catenin signaling in cancer stemness and malignant behavior,” Current Opinion in Cell Biology, vol. 19, no. 2, pp. 150–158, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Locke, M. Heywood, S. Fawell, and I. C. Mackenzie, “Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines,” Cancer Research, vol. 65, no. 19, pp. 8944–8950, 2005. View at Publisher · View at Google Scholar · View at Scopus